Patents by Inventor Bobba Venkata Siva Kumar

Bobba Venkata Siva Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8624041
    Abstract: A process for the preparation of strontium ranelate or a hydrate thereof is provided comprising (a) reacting a tetraester compound of Formula II: wherein R, R1, R2, and R3 are independently a linear or branched C1-C6 alkyl group or a substituted or unsubstituted C3-C12 cyclic group, in the presence of a lithium base and in a solvent with an inorganic acid salt of strontium.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: January 7, 2014
    Assignee: Glenmark Generics Ltd.
    Inventors: Bobba Venkata Siva Kumar, Kosampally Srinivas, Sanjay Anantha Kale, Nitin Sharad Chandra Pradhan
  • Publication number: 20100286208
    Abstract: Disclosed is a novel potassium salt of esomeprazole in polymorph form X, which can be used in pharmaceutical compositions. Processes for preparing polymorph form X of esomeprazole potassium are also provided.
    Type: Application
    Filed: June 21, 2007
    Publication date: November 11, 2010
    Inventors: Bobba Venkata Siva Kumar, Pravin BalachandrA Kulkarni, Anil Ganpat Suryawanshi, Sachin Bapurao Sawant
  • Patent number: 7649096
    Abstract: A process for preparing a crystalline form of linezolid is provided comprising (a) providing a solution comprising linezolid in an organic solvent having a boiling point of less than or equal to about 150° C.; (b) adding an anti-solvent having a boiling point greater than or equal to about 50° C. to the solution; and (c) recovering the crystalline form of linezolid.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: January 19, 2010
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Siva Kumar, Pravin Bhalchandra Kulkarni, Girish Bansilal Patel, Nitin Sharad Chandra Pradhan
  • Publication number: 20090298884
    Abstract: A strontium salt of esomeprazole is provided. A process for preparing a strontium salt of esomeprazole is also provided comprising reacting esomeprazole free base or a sodium, potassium or lithium salt of esomeprazole with a strontium source in one or more solvents.
    Type: Application
    Filed: May 2, 2006
    Publication date: December 3, 2009
    Applicant: GLENMARK GENERICS LTD.
    Inventors: Shekhar Bhaskar Bhirud, Nitin Sharad Chandra Pradhan, Bobba Venkata Siva Kumar, Pravin Bhalchandra Kulkarni
  • Publication number: 20090214631
    Abstract: A process for the preparation of strontium ranelate or a hydrate thereof is provided comprising (a) reacting a tetraester compound of Formula II: wherein R, R1, R2, and R3 are independently a linear or branched C1-C6 alkyl group or a substituted or unsubstituted C3-C12 cyclic group, in the presence of a lithium base and in a solvent with an inorganic acid salt of strontium.
    Type: Application
    Filed: August 18, 2006
    Publication date: August 27, 2009
    Inventors: Bobba Venkata Siva Kumar, Kosampally Srinivas, Sanjay Anantha Kale, Nitin Sharad Chandra Pradhan
  • Patent number: 7414143
    Abstract: An improved process for the preparation of key intermediates for tazarotene, 4,4-dimethyl-6-ethynylthiochroman, is provided comprising (a) reacting 4,4-dimethyl-6-acetylthiochroman of the formula with an acid chloride and an amido-group containing compound of the general formula wherein R is hydrogen or a hydrocarbyl of from 1 to 15 carbon atoms and R1 and R2 can be the same or different and are hydrocarbyls of from 1 to 15 carbon atoms or R1 and R2 together with the nitrogen atom to which they are bonded are joined together to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms, or one of R1 and R2 together with the nitrogen atom to which it bonded are joined together with the carbonyl radical to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms to form a ?-chloro vinyl carbonyl compound intermediate of the general formula wherein R has the aforestated meanings; and (b) reacting the ?-chloro vinyl carbonyl compound
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: August 19, 2008
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Siva Kumar, Vishvas Dattatraya Patil, Changdev Namdev Raut, Shekhar Bhaskar Bhirud, Batchu Chandrasekhar
  • Publication number: 20070105923
    Abstract: A process for purifying olmesartan medoxomil is provided comprising (a) dissolving olmesartan medoxomil in a solvent system comprising a ketone and at least one solvent selected from the group consisting of an alcohol-containing solvent, an ester-containing solvent and mixtures thereof to obtain a solution; and (b) recovering substantially pure olmesartan medoxomil. Also disclosed is substantially pure olmesartan medoxomil and pharmaceutical compositions containing same.
    Type: Application
    Filed: September 14, 2006
    Publication date: May 10, 2007
    Applicant: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Siva Kumar, Sanjay Kale, Raju Choudhari, Nitin Sharad Pradhan
  • Patent number: 6963002
    Abstract: An improved process for the preparation of key intermediates for tazarotene, 4,4-dimethyl-6-ethynylthiochroman, is provided comprising (a) reacting 4,4-dimethyl-6-acetylthiochroman of the formula with an acid chloride and an amido-group containing compound of the general formula wherein R is hydrogen or a hydrocarbyl of from 1 to 15 carbon atoms and R1 and R2 can be the same or different and are hydrocarbyls of from 1 to 15 carbon atoms or R1 and R2 together with the nitrogen atom to which they are bonded are joined together to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms, or one of R1 and R2 together with the nitrogen atom to which it bonded are joined together with the carbonyl radical to form a heterocyclic group, optionally containing one or more additional heterocyclic atoms to form a ?-chloro vinyl carbonyl compound intermediate of the general formula wherein R has the aforestated meanings; and (b) reacting the ?-chloro vinyl carbonyl compound in
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: November 8, 2005
    Assignee: Glenmark Pharmaceuticals Limited
    Inventors: Bobba Venkata Siva Kumar, Vishvas Dattatraya Patil, Changdev Namdev Raut, Shekhar Bhaskar Bhirud, Batchu Chandrasekhar